Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paul

Showing results (531-540 of 763) with videos related to

Pageof 77
Sort By:
Clinical Genetics|December 1, 2022
Expansion of the phenotypic and molecular spectrum of CWF19L1-related disorderCarolina Alvarez, Mona Grimmel, Darius Ebrahimi-Fakhari, et al.
Nutritional Neuroscience|August 4, 2018
Cross-sectional association of seafood consumption, polyunsaturated fatty acids and depressive symptoms in two Torres Strait communitiesMaximus Berger, Sean Taylor, Linton Harriss, et al.
BMC Psychiatry|September 22, 2016
Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?Melanie Föcking, Patrick Dicker, Lorna M Lopez, et al.
Schizophrenia Research|July 12, 2011
Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up studyG Paul Amminger, Lisa P Henry, Susy M Harrigan, et al.
Bioanalysis|December 4, 2013
Sensitive glucagon quantification by immunochemical and LC-MS/MS methodsVeniamin N Lapko, Patrick S Miller, G Paul Brown, et al.
Journal of Thrombosis and Haemostasis : JTH|December 14, 2020
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductaseXuejie Chen, Yizhou Liu, Natsuko Furukawa, et al.
Frontiers in Chemistry|May 3, 2024
Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by pieceBill W G L Chan, Nicholas B Lynch, Wendy Tran, et al.
The Veterinary Record|January 16, 2007
Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2A A C Jacobs, J G H E Bergman, R P H Theelen, et al.
Bioorganic & Medicinal Chemistry|June 1, 2005
Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptorsDavid Barker, Diana H-S Lin, Jane E Carland, et al.
The Journal of Organic Chemistry|June 5, 2013
Chloroform as a hydrogen atom donor in Barton reductive decarboxylation reactionsJunming Ho, Jingjing Zheng, Rubén Meana-Pañeda, et al.
Pageof 77

Showing results (531-540 of 763) with videos related to

Sort By:
Pageof 77
Clinical Genetics|December 1, 2022
Expansion of the phenotypic and molecular spectrum of CWF19L1-related disorderCarolina Alvarez, Mona Grimmel, Darius Ebrahimi-Fakhari, et al.
Nutritional Neuroscience|August 4, 2018
Cross-sectional association of seafood consumption, polyunsaturated fatty acids and depressive symptoms in two Torres Strait communitiesMaximus Berger, Sean Taylor, Linton Harriss, et al.
BMC Psychiatry|September 22, 2016
Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?Melanie Föcking, Patrick Dicker, Lorna M Lopez, et al.
Schizophrenia Research|July 12, 2011
Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up studyG Paul Amminger, Lisa P Henry, Susy M Harrigan, et al.
Bioanalysis|December 4, 2013
Sensitive glucagon quantification by immunochemical and LC-MS/MS methodsVeniamin N Lapko, Patrick S Miller, G Paul Brown, et al.
Journal of Thrombosis and Haemostasis : JTH|December 14, 2020
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductaseXuejie Chen, Yizhou Liu, Natsuko Furukawa, et al.
Frontiers in Chemistry|May 3, 2024
Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by pieceBill W G L Chan, Nicholas B Lynch, Wendy Tran, et al.
The Veterinary Record|January 16, 2007
Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2A A C Jacobs, J G H E Bergman, R P H Theelen, et al.
Bioorganic & Medicinal Chemistry|June 1, 2005
Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptorsDavid Barker, Diana H-S Lin, Jane E Carland, et al.
The Journal of Organic Chemistry|June 5, 2013
Chloroform as a hydrogen atom donor in Barton reductive decarboxylation reactionsJunming Ho, Jingjing Zheng, Rubén Meana-Pañeda, et al.
Pageof 77